Abstract

Asynchronous ventricular pacing has been shown to increase the risk of development of atrial fibrillation (AF) because of various mechanisms: retrograde atrioventricular (AV) conduction with increase in atrial pressure causing acute atrial stretch and reverse flow in the pulmonary veins, mitral regurgitation, reduced coronary blood flow, adverse neuroendocrine reactions, etc. Dual-chamber pacing preserves atrioventricular synchrony. However, in randomized multicentre trials comparing VVI(R) with DDD(R) pacing, AF is only slightly less frequent in the dual-chamber mode. This is most likely due to unnecessary ventricular pacing, which is frequent in dual-chamber pacing. At nominal values, dual-chamber devices usually do not permit intrinsic AV conduction but promote delivery of the ventricular stimulus at an inappropriate time in an inappropriate place. Programming of long AV delays facilitates spontaneous AV conduction but usually cannot completely avoid unnecessary ventricular pacing and causes other problems in the dual-chamber mode. Atrial septal lead placement can improve left-sided AV synchrony and promote spontaneous AV conduction. Programming of the AAI(R) mode is superior to the dual-chamber mode but cannot be used if AV conduction is impaired intermittently or permanently. Therefore, dedicated algorithms enhancing spontaneous AV conduction in the dual-chamber mode are desirable for a large proportion of pacemaker patients.

Introduction

Atrial fibrillation (AF) is a common complication in patients with permanent pacemaker therapy. Although its incidence is influenced by the presence of structural heart disease, hypertension, congestive heart failure, or AF before pacemaker implantation, the pacing mode may also have a significant influence on the development of AF. This review provides insights into the haemodynamic properties of VVI and DDD pacing modes with regard to their potential to promote the development of AF.

Haemodynamic consequences of VVI pacing

Adverse haemodynamic and electrophysiological effects of VVI pacing during sinus rhythm have been well appreciated. Twenty years ago, the pacemaker syndrome was described,1 which is caused by haemodynamic deterioration due to loss of AV synchrony (or even due to VA synchrony), mitral regurgitation, inter-/intraventricular asynchrony, arrhythmia induction, and neuroendocrine reflexes. Adverse haemodynamic consequences of VVI pacing during sinus rhythm are most prominent if retrograde conduction is present. Particularly, at a VA interval of 100 ms, there may be a strong ‘negative atrial kick’ caused by atrial contraction against closed AV valves. This may reduce cardiac output and lead to pacemaker syndrome due to reflexes causing a fall in peripheral vascular resistance, and it should also be noted that ventricular pacing with retrograde 1:1 conduction causes a strong increase in atrial pressure and regurgitation into the pulmonary veins (Fig. 1). These so-called z-waves or ‘cannon waves’ may lead to a considerable distension of pulmonary veins, which may represent a potent trigger for AF. Even if no retrograde conduction is present, interference between sinus rate and VVI pacing rate leads to a periodicity in which P-waves shift until they appear after a ventricular pace, mimicking retrograde conduction (Fig. 2). As focal electrical activity in the pulmonary veins and acute atrial stretch have been recognized as two of the most important AF triggers in patients with and without structural heart disease,2 it may be concluded that asynchronous ventricular pacing in the VVI mode with or without retrograde conduction is a potent trigger for AF induction.

Ventricular pacing with 1:1 retrograde conduction. In this transoesophageal pulsed-Doppler echocardiographic recording, positive values depict antegrade flow in a pulmonary vein, whereas negative values depict retrograde flow. After each ventricular stimulus (see ECG at the bottom of the tracing), a retrograde P-wave appears, resulting in regurgitation into the pulmonary vein (z-wave). With permission from Stierle et al.37
Figure 1

Ventricular pacing with 1:1 retrograde conduction. In this transoesophageal pulsed-Doppler echocardiographic recording, positive values depict antegrade flow in a pulmonary vein, whereas negative values depict retrograde flow. After each ventricular stimulus (see ECG at the bottom of the tracing), a retrograde P-wave appears, resulting in regurgitation into the pulmonary vein (z-wave). With permission from Stierle et al.37

Ventricular pacing without retrograde conduction. Transoesophageal pulsed-Doppler echocardiographic recording as in Fig. 1. With VVI pacing rate (75 bpm) different from the sinus rate, P-waves appear shortly after the ventricular stimulus in three out of five cycles, resulting in regurgitation into the pulmonary vein (z-wave as in Fig. 1). With permission from Stierle et al.37
Figure 2

Ventricular pacing without retrograde conduction. Transoesophageal pulsed-Doppler echocardiographic recording as in Fig. 1. With VVI pacing rate (75 bpm) different from the sinus rate, P-waves appear shortly after the ventricular stimulus in three out of five cycles, resulting in regurgitation into the pulmonary vein (z-wave as in Fig. 1). With permission from Stierle et al.37

While permanent or intermittent atrial contraction against closed AV valves causes atrial/pulmonary vein distension as one trigger of AF, another AF trigger is represented by mitral regurgitation caused by right ventricular pacing,3–6 which can sometimes be reversed by dual-chamber pacing.3,5 Owing to mitral regurgitation, ventricular pacing leads to an elevation in pulmonary capillary wedge pressure and increases the risk of AF. Elevated atrial natriuretic peptide levels observed in patients with VVI pacing7 may further document atrial pressure increase with the potential to induce AF.

Likewise, it has been shown in animal and human studies that ventricular pacing reduces coronary blood flow,8–10 increases tissue norepinephrine levels,10 and deteriorates the relationship between left ventricular output and myocardial oxygen consumption.11 By these mechanisms, VVI pacing may produce ischaemia which may promote the development of AF. Finally, asynchronous ventricular pacing induces electrical and mechanical atrial remodelling, which may facilitate the induction of AF and thrombus formation in the left-atrial appendage.12,13

AF in VVI and DDD pacing: randomized and non-randomized data

In accordance with this picture of how VVI pacing may cause AF, retrospective and non-randomized studies show a yearly AF incidence of 7% with VVI pacing in contrast to 2% in patients with AAI or DDD pacing14–27 (Table 1). Also, several large-scale randomized trials confirm that AF develops more frequently in VVI(R) than in DDD(R) pacing mode28–35 (Table 2). However, in these studies, the absolute difference in AF development converges to 1.2% and is thus much smaller than expected, given the adverse effects of VVI pacing as outlined earlier in contrast to dual-chamber pacing which attempts to reproduce physiological atrioventricular timing.

Table 1

Association between pacing mode and the rate of AF in non-randomized observational studies (meta-analysis by Barold and Israel59)

AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/DDD pacing (% per year)AF in VVI pacing (% per year)

Sutton and Kenny141986112121181.46.8
Markewitz et al.1519863602323.110.0
Ebagosti et al.1619881982102.05.2
Langenfeld et al.17198811511500.95.4
Rosenqvist et al.1819883293071.812.1
Sasaki et al.1919883973012.3
Bianconi et al.2019895587434.87.9
Feuer et al.2119893674402.54.5
Santini et al.22199010914911.411.8
Stangl et al.2319904775041.54.2
Zanini et al.2419901991901.05.3
Nürnberg et al.2519911263184.811.0
Hesselsson et al.261992145310451.45.3
Sgarbossa et al.2719932173616aa
Total/mean915292331.97.0
AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/DDD pacing (% per year)AF in VVI pacing (% per year)

Sutton and Kenny141986112121181.46.8
Markewitz et al.1519863602323.110.0
Ebagosti et al.1619881982102.05.2
Langenfeld et al.17198811511500.95.4
Rosenqvist et al.1819883293071.812.1
Sasaki et al.1919883973012.3
Bianconi et al.2019895587434.87.9
Feuer et al.2119893674402.54.5
Santini et al.22199010914911.411.8
Stangl et al.2319904775041.54.2
Zanini et al.2419901991901.05.3
Nürnberg et al.2519911263184.811.0
Hesselsson et al.261992145310451.45.3
Sgarbossa et al.2719932173616aa
Total/mean915292331.97.0

aMultivariate analysis identified ventricular pacing as an independent predictor of chronic AF.

Table 1

Association between pacing mode and the rate of AF in non-randomized observational studies (meta-analysis by Barold and Israel59)

AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/DDD pacing (% per year)AF in VVI pacing (% per year)

Sutton and Kenny141986112121181.46.8
Markewitz et al.1519863602323.110.0
Ebagosti et al.1619881982102.05.2
Langenfeld et al.17198811511500.95.4
Rosenqvist et al.1819883293071.812.1
Sasaki et al.1919883973012.3
Bianconi et al.2019895587434.87.9
Feuer et al.2119893674402.54.5
Santini et al.22199010914911.411.8
Stangl et al.2319904775041.54.2
Zanini et al.2419901991901.05.3
Nürnberg et al.2519911263184.811.0
Hesselsson et al.261992145310451.45.3
Sgarbossa et al.2719932173616aa
Total/mean915292331.97.0
AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/DDD pacing (% per year)AF in VVI pacing (% per year)

Sutton and Kenny141986112121181.46.8
Markewitz et al.1519863602323.110.0
Ebagosti et al.1619881982102.05.2
Langenfeld et al.17198811511500.95.4
Rosenqvist et al.1819883293071.812.1
Sasaki et al.1919883973012.3
Bianconi et al.2019895587434.87.9
Feuer et al.2119893674402.54.5
Santini et al.22199010914911.411.8
Stangl et al.2319904775041.54.2
Zanini et al.2419901991901.05.3
Nürnberg et al.2519911263184.811.0
Hesselsson et al.261992145310451.45.3
Sgarbossa et al.2719932173616aa
Total/mean915292331.97.0

aMultivariate analysis identified ventricular pacing as an independent predictor of chronic AF.

Table 2

Association between pacing mode and the rate of AF in randomized studies

AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/ DDD pacing (% per year)AF in VVI pacing (% per year)

Andersen et al.2819971101154.16.6
Wharton et al.291998100984843
Lamas et al.3019982032046.97.5
Connolly et al.312000109414745.36.6
Lamas et al.32200210149967.89.9
Kerr et al.332004(1014)a(996)a4.55.7
Toff et al.34200310121009bb
Wilkoff et al.35200225025602.1
Total/mean378341526.67.8
AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/ DDD pacing (% per year)AF in VVI pacing (% per year)

Andersen et al.2819971101154.16.6
Wharton et al.291998100984843
Lamas et al.3019982032046.97.5
Connolly et al.312000109414745.36.6
Lamas et al.32200210149967.89.9
Kerr et al.332004(1014)a(996)a4.55.7
Toff et al.34200310121009bb
Wilkoff et al.35200225025602.1
Total/mean378341526.67.8

a2002 patients of the CTOPP trial were eligible for the extended follow-up study.

bNo significant difference between AAI(R)/DDD(R) and VVI(R).

Table 2

Association between pacing mode and the rate of AF in randomized studies

AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/ DDD pacing (% per year)AF in VVI pacing (% per year)

Andersen et al.2819971101154.16.6
Wharton et al.291998100984843
Lamas et al.3019982032046.97.5
Connolly et al.312000109414745.36.6
Lamas et al.32200210149967.89.9
Kerr et al.332004(1014)a(996)a4.55.7
Toff et al.34200310121009bb
Wilkoff et al.35200225025602.1
Total/mean378341526.67.8
AuthorYearPatients with AAI/DDD (n)Patients with VVI(R) (n)AF in AAI/ DDD pacing (% per year)AF in VVI pacing (% per year)

Andersen et al.2819971101154.16.6
Wharton et al.291998100984843
Lamas et al.3019982032046.97.5
Connolly et al.312000109414745.36.6
Lamas et al.32200210149967.89.9
Kerr et al.332004(1014)a(996)a4.55.7
Toff et al.34200310121009bb
Wilkoff et al.35200225025602.1
Total/mean378341526.67.8

a2002 patients of the CTOPP trial were eligible for the extended follow-up study.

bNo significant difference between AAI(R)/DDD(R) and VVI(R).

For instance, in patients with sick sinus syndrome, the MOST trial showed little difference between VVIR and DDDR pacing for various clinical endpoints.32 The development of AF differed (absolutely) by only 2.1%. However, patients required antibradycardia pacing for only 58% of the time in VVIR mode, whereas ventricular pacing was present for 90% of the time in patients randomized to DDDR pacing.36 This is even more remarkable as only patients with sinus node disease were included; therefore, ventricular pacing was unnecessary in the vast majority of patients and was due to programming of a short AV delay. In a subanalysis, Sweeney et al.36 observed an association between the percentage of ventricular pacing and the development of AF. Patients paced in VVIR mode for <10% of the time developed AF in only 21%, whereas VVIR pacing for 50–90% of the time was associated with AF 29% of patients. Interestingly, a similar and even stronger association between ventricular pacing and development of AF was found for the DDDR mode where ventricular pacing for <10% of the time was associated with AF in 16% of the patients in contrast to AF in 32% of patients with ventricular pacing for 50–90% of the time.36 In this subanalysis, it looked as if ventricular pacing was even more deleterious in the DDDR mode than in the VVIR mode: The risk of AF increased by 1% for each per cent increase in ventricular pacing in the DDDR mode when compared with only 0.7% for each per cent increase in the VVIR mode. This observation poses the question why right ventricular pacing in atrioventricular synchronous or sequential pacing may be at least as harmful as asynchronous ventricular pacing.

Consequences of DDD pacing with nominal AV delay

To study the haemodynamic consequences of ventricular pacing in the dual-chamber mode, a study using Doppler ultrasound in the pulmonary veins is quite revealing.37 If a short AV interval was programmed, 2 of 14 patients had retrograde pulmonary vein flow (z-waves in Fig. 3) similar to VVI pacing. In both patients, symptoms of pacemaker syndrome appeared despite dual-chamber pacing which were reversible by prolonging the AV delay. The appearance of pacemaker syndrome in the dual-chamber mode can be explained by recordings of left-atrial activity, e.g. by transoesophageal ECGs38. These show an interatrial conduction delay (IACD) in a significant number of patients, particularly if they are elderly39 or if left-atrial dilatation is present.40 In 100 patients, the mean IACD was 70 ms in sinus rhythm and 120 ms if the right atrium was paced.40 However, IACD can postpone left-atrial activation by 130 ms or more.38,39,41 Thus, with a programmed AV delay of 120 ms (nominal value in many dual-chamber pacemakers), left-sided AV intervals can be very short if intraventricular conduction is normal (Fig. 4) and may even be negative (Fig. 5),38 i.e. left-atrial activation occurs after ventricular pacing. Therefore, seemingly ‘physiological’ dual-chamber pacing can lead to a considerably unfavourable haemodynamic situation. The association of IACD and atrial tachyarrhythmias has been well established42,43 as has been the development of atrial electrical remodelling in response to even small increases in left-atrial pressure.44 Even though adverse haemodynamic effects of ‘untimely’ ventricular pacing in the dual-chamber mode have, therefore, long been recognized and several formulae for optimizing the AV delay with the use of echocardiography have been proposed,45 this has not been considered in large multicentre trials comparing VVI(R) with DDD(R) pacing. Additionally, pacemaker manufacturers have obviously not been aware of the potential implications of inappropriately programmed AV intervals because even today most dual-chamber pacemakers are still shipped with nominal AV delays of 120 ms or similar. Some pacemaker and ICD devices even force programming of rate adaptive AV delays of 30 ms as an interlock if the mode switching algorithm is activated.

Dual-chamber pacing causing retrograde flow in the pulmonary vein. Transoesophageal pulsed-Doppler echocardiographic recording as in Figs. 1 and 2. With an AV delay of 100 ms (AVI 100, left panel), a large z-wave representing retrograde flow in the pulmonary vein appears. This z-wave is diminished but not abolished by reprogramming the AV delay to 140 ms (AVI 140, middle panel). Only after prolonging the paced AV delay to 200 ms (AVI 200, right panel), there is no longer retrograde flow in the pulmonary veins. With permission from Stierle et al.37
Figure 3

Dual-chamber pacing causing retrograde flow in the pulmonary vein. Transoesophageal pulsed-Doppler echocardiographic recording as in Figs. 1 and 2. With an AV delay of 100 ms (AVI 100, left panel), a large z-wave representing retrograde flow in the pulmonary vein appears. This z-wave is diminished but not abolished by reprogramming the AV delay to 140 ms (AVI 140, middle panel). Only after prolonging the paced AV delay to 200 ms (AVI 200, right panel), there is no longer retrograde flow in the pulmonary veins. With permission from Stierle et al.37

Example of the left-sided AV interval in IACD. In this case, an IACD of 130 ms, an interventricular conduction delay of 50 ms (mean value in Chirife et al.41), and a programmed AV delay of 140 ms would lead to a left-sided AV interval of only 60 ms.
Figure 4

Example of the left-sided AV interval in IACD. In this case, an IACD of 130 ms, an interventricular conduction delay of 50 ms (mean value in Chirife et al.41), and a programmed AV delay of 140 ms would lead to a left-sided AV interval of only 60 ms.

Left-atrial activation in relation to ventricular pacing in the DDDR/DDIR mode. After atrial pacing, left-atrial activity as measured with a transoesophageal left-atrial electrogram (LA-EGM) is delayed. Thus, in this case, ventricular stimulation occurs before left-atrial activity if the AV delay is programmed to 150 ms. Only after prolongation of the AV delay to 270 ms, left-atrial activation occurs just before the ventricular pacing spike. With permission from Ismer et al.38
Figure 5

Left-atrial activation in relation to ventricular pacing in the DDDR/DDIR mode. After atrial pacing, left-atrial activity as measured with a transoesophageal left-atrial electrogram (LA-EGM) is delayed. Thus, in this case, ventricular stimulation occurs before left-atrial activity if the AV delay is programmed to 150 ms. Only after prolongation of the AV delay to 270 ms, left-atrial activation occurs just before the ventricular pacing spike. With permission from Ismer et al.38

Therefore, instead of delivering atrioventricular activation sequences that mimic physiological behaviour, poorly programmed dual-chamber devices may apply a ventricular stimulus at a time when the left atrium is activated. This is haemodynamically equivalent to VVI pacing with 1:1 retrograde conduction. Due to maintenance of short nominal AV delays, patients with dual-chamber devices received much more unnecessary ventricular pacing than patients with VVI devices in the MOST and DAVID trials.35,36 As a result, many patients with dual-chamber devices may have experienced AV desynchronization, and AF may have developed much less frequently if spontaneous AV conduction had been permitted.

Dual-chamber pacing with long AV delay

In the light of the disappointing results of dual-chamber pacing and for the reasons just outlined, attempts have been made to avoid unnecessary ventricular pacing in patients without high-degree AV block by programming long AV delays (e.g. 300 ms) and DDI(R) instead of DDD(R) mode. In a study of 177 patients with sick sinus syndrome and normal AV conduction, patients were randomized to AAI(R) and DDD(R) with short AV delay (≤150 ms) or long AV delay (300 ms).46 Interestingly, patients randomized to DDD(R) with long AV delay still received 17% ventricular pacing (most likely fusion and pseudo-fusion), and this percentage was sufficient to cause significantly more AF than AAI(R) pacing and only moderately less than DDD(R) pacing with a short AV delay, which led to ventricular pacing for 90% of the time. Intrinsic AV conduction may vary considerably and can be unexpectedly long in atrial paced rhythm and during night.47 Also, an inappropriate atrial rate increase (e.g. due to sensor over-reactivity or atrial preventive pacing algorithms) increases the intrinsic AV delay and promotes ventricular pacing (Fig. 6). Of note, most multicentre trials comparing single- and dual-chamber pacing used rate responsive pacing for all patients even without any clinical signs of chronotropic sinus node incompetence (e.g. DAVID, PASE, MOST).30,32,35 Also, in trials on atrial preventive pacing algorithms, the ventricle was typically paced for 70–95% of the time despite the fact that most patients only had sinus node disease with normal AV conduction. In the PIPAF study, the subgroup of patients with a low percentage of ventricular pacing (mean 26%) due to programming of the AV delay to a mean of 261 ms received a benefit from atrial preventive pacing, whereas in patients with a high percentage of ventricular pacing (mean 99%) due to programming of a relatively short AV delay (mean 176 ms), the time in AF even increased slightly during atrial preventive pacing.48

Example of a prolongation of the intrinsic AV conduction due to inappropriately fast atrial pacing. In this patient, an automatic sensor adjustment algorithm has increased the pacing rate to approximately 90 bpm at rest. This prolonged spontaneous AV conduction to approximately 300 ms causing ventricular fusion beats even with an AV delay programmed to 300 ms (A). After reprogramming the sensor, dual-chamber pacing at rest occurs at the lower rate limit of 70 bpm (B). Now, the spontaneous AV delay shortens again to 220 ms. Leads I–III, paper speed 50 mm/s.
Figure 6

Example of a prolongation of the intrinsic AV conduction due to inappropriately fast atrial pacing. In this patient, an automatic sensor adjustment algorithm has increased the pacing rate to approximately 90 bpm at rest. This prolonged spontaneous AV conduction to approximately 300 ms causing ventricular fusion beats even with an AV delay programmed to 300 ms (A). After reprogramming the sensor, dual-chamber pacing at rest occurs at the lower rate limit of 70 bpm (B). Now, the spontaneous AV delay shortens again to 220 ms. Leads I–III, paper speed 50 mm/s.

Finally, programming of long AV delays in DDD(R) or DDI(R) modes may cause additional problems such as a limitation of the maximum tracking rate, non-re-entrant VA synchrony,49 and pacing in the vulnerable phase of the T-wave after a ventricular premature beat which coincides with the atrial stimulus (Fig. 7).

Ventricular pacing in the T-wave after a ventricular premature beat. If a ventricular premature beat coincides with the atrial stimulus, it may be sensed by the ventricular lead causing safety window pacing (first complex in the tracing) or it may be completely blanked out and the ventricular pace appears at the programmed AV delay (second complex from the right). The longer the AV delay is programmed, the more like the ventricular pace may capture in the ventricular vulnerable phase.
Figure 7

Ventricular pacing in the T-wave after a ventricular premature beat. If a ventricular premature beat coincides with the atrial stimulus, it may be sensed by the ventricular lead causing safety window pacing (first complex in the tracing) or it may be completely blanked out and the ventricular pace appears at the programmed AV delay (second complex from the right). The longer the AV delay is programmed, the more like the ventricular pace may capture in the ventricular vulnerable phase.

In conclusion, dual-chamber pacing with long AV delay does not seem to avoid unnecessary ventricular pacing sufficiently to be as effective in preventing AF as AAIR pacing in patients with normal AV conduction, and causes new problems.

Atrial septal pacing in DDD mode

Apart from the pacing mode, the atrial lead position may determine the risk of AF development. Lead implantation in the right atrial appendage or high lateral right atrium seems to promote electrical desynchronization of the atria,50–52 which becomes visible by a prolongation of the paced P-wave compared with the sinus P-wave (Fig. 8). At the same time, induction of AF by an extrastimulus is easier if the atrium is paced from these positions than from the low atrial septum near the coronary sinus ostium or from the high septum near the right atrial insertion of Bachmann's bundle.53 Pacing at these atrial septal positions is associated with a shorter P-wave than in sinus rhythm (Fig. 8) due to electrical connections of right and left atrium via Bachmann's bundle or connecting fibres in the coronary sinus.54 As a result, pacing near Bachmann's bundle was associated with less frequent development of AF during DDDR pacing than pacing from the right atrial appendage.55 Similarly, the effect of atrial overdrive pacing to prevent AF was more pronounced if the atrial electrode was implanted at the low atrial septum than in the right atrial appendage56. Also, AAIR pacing from the right atrial appendage or high lateral right atrium may be associated with a prolonged intrinsic AV conduction and may produce a ‘pseudo-pacemaker syndrome’ with left-atrial contraction coincident with left ventricular contraction (atrial pacing spike typically within the T-wave).57,58 Of note, especially pacing at the low atrial septum is associated with a short intrinsic AV interval. Thus, for identical AV delays, ventricular pacing is less likely for atrial electrodes positioned at the low atrial septum when compared with the high right atrium. Prevention of unnecessary ventricular pacing should also be included as a mechanism for how atrial septal pacing may prevent AF.

Intrinsic vs. paced P-wave duration and morphology: impact of atrial pacing site. In a patient with IACD (A, intrinsic P-wave duration 210 ms), P-wave duration is prolonged to 240 ms and P-wave morphology is further distorted if atrial pacing is performed from the lateral high right atrium (B). Any AV delay <240 ms will pace the ventricle before the end of atrial depolarization. In a patient with an intrinsic P-wave of 130 ms (C), atrial septal pacing near Bachmann's bundle synchronizes right- and left-atrial activation leading to a rather narrow peak of the P-wave and in this case to a small decrease of P-wave duration to 100 ms (D). Paper speed 100 mm/s, lead II and atrial electrograms. A: atrial pace; P: atrial-sensed event; R: ventricular sensed event; numbers: atrial cycle length, AV delay, VA interval and ventricular cycle length in ms.
Figure 8

Intrinsic vs. paced P-wave duration and morphology: impact of atrial pacing site. In a patient with IACD (A, intrinsic P-wave duration 210 ms), P-wave duration is prolonged to 240 ms and P-wave morphology is further distorted if atrial pacing is performed from the lateral high right atrium (B). Any AV delay <240 ms will pace the ventricle before the end of atrial depolarization. In a patient with an intrinsic P-wave of 130 ms (C), atrial septal pacing near Bachmann's bundle synchronizes right- and left-atrial activation leading to a rather narrow peak of the P-wave and in this case to a small decrease of P-wave duration to 100 ms (D). Paper speed 100 mm/s, lead II and atrial electrograms. A: atrial pace; P: atrial-sensed event; R: ventricular sensed event; numbers: atrial cycle length, AV delay, VA interval and ventricular cycle length in ms.

Conclusion

Ventricular pacing in the VVI(R) mode and also in the DDD(R)/DDI(R) modes seems to be associated with the development of AF. In the VVI(R) mode, AF may be triggered by retrograde conduction or simple coincidence of sinus beat and ventricular stimulus and atrial stretch. In the dual-chamber mode, inappropriate timing of ventricular pacing causes inappropriate left-sided AV intervals, in the worst case synchronizing left-atrial contraction with left ventricular activation. Thus, inappropriately programmed dual-chamber devices may cause AV dissociation or VA synchrony similar to VVI pacing with 1:1 retrograde conduction. Unnecessary (right) ventricular pacing, even if it causes only fusion or pseudo-fusion, should therefore be avoided as much as possible, and intrinsic AV conduction should usually be preferred to ventricular pacing. Inappropriate, fast atrial pacing rates (over-reactive sensor, preventive pacing algorithm) can significantly prolong intrinsic AV conduction and should be avoided. Programming of a long AV interval or DDI(R) instead of DDD(R) mode only partially solves this problem. Atrial septal lead position may compensate for IACD and thus promote more physiological left-sided AV intervals; by a low septal atrial lead position also, the intrinsic AV conduction may be improved. In patients with intact AV conduction, the AAI(R) mode is superior to dual-chamber modes and should be the mode of choice whenever possible. However, if AV conduction is impaired intermittently or permanently, other measures have to be sought to minimize unnecessary ventricular pacing.

References

1

Ausubel
K
Furman
S
The pacemaker syndrome.
Ann Intern Med
1985
103
420
9
.

2

Allessie
M
Boyden
P
Camm
AJ
Kleber
AG
Lab
MJ
Legato
MJ
et al.
Pathophysiology and prevention of atrial fibrillation.
Circulation
2001
103
769
77
.

3

Berglund
H
Nishioka
T
Hackner
E
Kim
CJ
Luo
H
Fontana
G
et al.
Ventricular pacing: a cause of reversible severe mitral regurgitation.
Am Heart J
1996
131
1035
7
.

4

Cannan
CR
Higano
ST
Holmes
DR
Pacemaker induced mitral regurgitation: an alternative form of pacemaker syndrome.
Pacing Clin Electrophysiol
1997
20
735
8
.

5

Ishikawa
T
Sumita
S
Kikuchi
M
Satoh
S
Terada
K
Kuji
N
et al.
Diastolic mitral regurgitation when the heart rate is normalised by ventricular pacing.
Eur J Cardiac Pacing Electrophysiol
1996
6
23
7
.

6

Maurer
G
Torres
MA
Corday
E
Haendchen
RV
Meerbaum
S
Two-dimensional echocardiographic contrast assessment of pacing-induced mitral regurgitation: relation to altered regional left ventricular function.
J Am Coll Cardiol
1984
3
986
91
.

7

Cabello
JB
Bordes
P
Mauri
M
Valle
M
Quiles
JA
Acute and chronic changes in atrial natriuretic factor induced by ventricular pacing: a self controlled clinical trial.
Pacing Clin Electrophysiol
1996
19
815
21
.

8

Amitzur
G
Manor
D
Pressman
A
Adam
D
Hammerman
H
Shofti
R
et al.
Modulation of the arterial coronary blood flow by asynchronous activation with ventricular pacing.
Pacing Clin Electrophysiol
1995
18
697
710
.

9

Kolettis
TM
Kremastinos
DT
Kyriakides
ZS
Tsirakos
A
Toutouzas
PK
Effects of atrial, ventricular, and atrioventricular sequential pacing on coronary flow reserve.
Pacing Clin Electrophysiol
1995
18
1628
35
.

10

Lee
MA
Dae
MW
Langberg
JL
Griffin
JC
Chin
MC
Finkbeiner
WE
et al.
Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology.
J Am Coll Cardiol
1994
24
225
32
.

11

Owen
CH
Esposito
DJ
Davis
JW
Glower
DD
The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs.
Pacing Clin Electrophysiol
1998
21
1417
29
.

12

Sparks
PB
Mond
HG
Vohra
JK
Yapanis
AG
Grigg
LE
Kalman
JM
Electrical remodeling of the atrial following loss of atrioventricular synchrony. A long-term study in humans.
Circulation
1999
100
1894
900
.

13

Sparks
PB
Mond
HG
Vohra
JK
Yapanis
AG
Grigg
LE
Kalman
JM
Mechanical remodeling of the atrial following loss of atrioventricular synchrony. A long-term study in humans.
Circulation
1999
100
1714
21
.

14

Sutton
R
Kenny
RA
The natural history of sick sinus syndrome.
Pacing Clin Electrophysiol
1986
9
1110
4
.

15

Markewitz
A
Schad
N
Hemmer
W
Bernheim
C
Ciavolella
M
Weinhold
C
What is the most appropriate stimulation mode in patients with sinus node dysfunction?
Pacing Clin Electrophysiol
1988
9
1115
20
.

16

Ebagosti
A
Gueuroun
M
Saadjian
A
Dolla
E
Gabriel
M
Levy
S
et al.
Long-term follow-up of patients treated with VVI pacing and sequential pacing with special reference to VA retrograde conduction.
Pacing Clin Electrophysiol
1988
11
1929
34
.

17

Langenfeld
H
Decoster
H
Verherstraeten
M
Kochsiek
K
Atrial fibrillation and embolic complications in paced patients.
Pacing Clin Electrophysiol
1988
11
1667
72
.

18

Rosenqvist
M
Brandt
J
Schüller
H
Long-term pacing in sinus node disease. Effects of stimulation mode on cardiovascular morbidity and mortality.
Am Heart J
1988
116
16
22
.

19

Sasaki
Y
Shimotori
M
Akahane
K
et al.
Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced and physiologically paced groups.
Pacing Clin Electrophysiol
1988
11
1575
83
.

20

Bianconi
L
Boccadamo
R
Di
Florio A
Carpino
A
Catalano
F
Stella
C
et al.
Atrial versus ventricular stimulation in sick sinus syndrome. Effect on morbidity and mortality. (Abstract).
Pacing Clin Electrophysiol
1989
12
1236A
.

21

Feuer
J
Shandling
A
Messenger
J
Influence of cardiac pacing mode on the long-term development of atrial fibrillation.
Am J Cardiol
1989
54
1376
9
.

22

Santini
M
Alexidou
G
Ansalone
G
et al.
Relation of prognosis in sick sinus syndrome to age, conduction defect, and modes of permanent cardiac pacing.
Am J Cardiol
1990
65
729
35
.

23

Stangl
K
Seitz
K
Wirtzfeld
A
et al.
Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome.
Pacing Clin Electrophysiol
1988
11
2080
5
.

24

Zanini
R
Facchinetti
AI
Gallo
G
et al.
Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing.
Pacing Clin Electrophysiol
1990
13
2076
9
.

25

Nürnberg
M
Frohner
K
Podczeck
A
et al.
Is VVI pacing more dangerous than AV sequential pacing in patients with sick sinus syndrome? (Abstract).
Pacing Clin Electrophysiol
1991
14
674
.

26

Hesselson
AB
Parsonnet
V
Bernstein
AD
Bonavita
GJ
Deleterious effect of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual chamber pacing.
J Am Coll Cardiol
1992
19
1542
9
.

27

Sgarbossa
EB
Pinski
SL
Maloney
JD
Simmons
TW
Wilkoff
BL
Castle
LW
et al.
Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities.
Circulation
1993
88
1045
53
.

28

Andersen
HR
Nielsen
JC
Thomsen
PE
Thuesen
L
Mortensen
PT
Vesterlund
T
et al.
Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome.
Lancet
1997
350
1210
6
.

29

Wharton
JM
Sorrentino
RA
Campbell
P
et al.
Effect on pacing modality on atrial tachyarrhythmia recurrence in the tachycardia–bradycardia syndrome: preliminary results of the pacemaker atrial tachycardia trial. (Abstract).
Circulation
1998
98
I-494
.

30

Lamas
GA
Orav
J
Stambler
BS
Ellenbogen
KA
Sgarbossa
EB
Huang
SK
et al.
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing.
N Engl J Med
1998
338
1097
104
.

31

Connolly
SJ
Kerr
CR
Gent
M
Roberts
RS
Yusuf
S
Gillis
AM
et al.
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
N Engl J Med
2000
342
1385
91
.

32

Lamas
GA
Lee
KA
Sweeney
MO
Leon
A
Yee
R
Marinchak
RA
et al.
Ventricular pacing or dual-chamber pacing for sinus node dysfunction.
N Engl J Med
2002
346
1854
62
.

33

Kerr
CR
Connolly
SJ
Abdollah
H
Roberts
RS
Gent
M
Yusuf
S
et al.
Canadian trial of physiologic pacing: effects of physiological pacing during long-term follow-up.
Circulation
2004
109
357
62
.

34

Toff
WD
Skene
AM
Camm
AJ
Skehan
JD
A prospective comparison of the clinical benefits of dual chamber versus single chamber ventricular pacing in elderly patients with high-grade ventricular block: The United Kingdom Pacing and Cardiovascular Events (UK-PACE) Trial.
Presented at the 52nd Annual Scientific Sessions of the American College of Cardiology, Chicacgo, March 31
2003
.

35

Wilkoff
B
Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator.
JAMA
2002
288
3115
23
.

36

Sweeney
MO
Hellkamp
AS
Ellenbogen
KA
Greenspon
AJ
Freedman
RA
Lee
KL
et al.
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
Circulation
2003
107
2932
37
.

37

Stierle
U
Krüger
D
Mitusch
R
Potratz
J
Taubert
G
Sheikhzadeh
A
Adverse pacemaker hemodynamics evaluated by pulmonary venous flow monitoring.
Pacing Clin Electrophysiol
1995
18
2028
34
.

38

Ismer
B
von Knorre
GH
Voss
W
Placke
J
Approximation of the individual optimal AV delay using left atrial electrocardiography.
Herzschrittm Elektrophysiol
2004
15
(suppl. 1)
I/33
8
.

39

Camous
JP
Raybaud
F
dolisi
C
Schenowitz
A
Varenne
A
Baudouy
M
Interatrial conduction in patients undergoing AV stimulation: effects of increasing atrial stimulation rate.
Pacing Clin Electrophysiol
1993
16
2082
6
.

40

Raybaud
F
Camous
JP
Benoit
P
Dolisi
C
Baudouy
M
Relationship between interatrial conduction times and left atrial dimensions in patients undergoing atrioventricular stimulation.
Pacing Clin Electrophysiol
1995
18
447
50
.

41

Chirife
R
Ortega
DF
Salazar
AI
Nonphysiological left heart AV intervals as a result of DDD and AAI ‘physiological’ pacing.
Pacing Clin Electrophysiol
1991
14
1752
6
.

42

Bayes
de Luna A
Cladellas
M
Oter
R
Torner
P
Guindo
J
Marti
V
et al.
Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia.
Eur Heart J
1988
9
1112
8
.

43

Daubert
JC
Pavin
D
Jauvert
G
Mabo
P
Intra- and interatrial conduction delay: implications for cardiac pacing.
Pacing Clin Electrophysiol
2004
27
507
25
.

44

Goette
A
Honeycutt
C
Geller
JC
Langberg
JJ
Klein
HU
Effect of right arial pressure on electrical remodeling during atrial fibrillation in dogs.
Herzschr Elektrophysiol
1999
10
51
8
.

45

Ritter
P
Vai
F
Pioger
G
Comparison between DDD and VVIR pacing modes: importance of atrioventricular delay programming. Implications for study protocols.
Eur J Cardiac Pacing Electrophysiol
1994
4
34
9
.

46

Nielssen
JC
Kristensen
L
Andersen
HR
Mortensen
PT
Pedersen
OL
Pedersen
AK
A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome.
J Am Coll Cardiol
2003
42
614
23
.

47

Sweeney
MO
Shea
JB
Fox
V
Adler
S
Nelson
L
Mullen
TJ
et al.
Randomized pilot study of a new atrial-based minimal pacing mode in dual-chamber implantable cardioverter-defibrillators.
Heart Rhythm
2004
1
160
7
.

48

Blanc
JJ
De
Roy L
Mansourati
J
Poezevara
Y
Marcon
JL
Schoels
W
et al.
Atrial pacing for prevention of atrial fibrillation. Assessment of simultaneously implemented algorithms.
Europace
2004
6
371
9
.

49

Sweeney
MO
Novel cause of spurious mode switching in dual-chamber pacemakers: atrioventricular desynchronization arrhythmia.
J Cardiovasc Electrophysiol
2002
13
616
9
.

50

Becker
R
Klinkott
R
Bauer
A
Senges
JC
Schreiner
KD
Voss
F
et al.
Multisite pacing for prevention of atrial tachyarrhythmias: potential mechanisms.
J Am Coll Cardiol
2000
35
1939
46
.

51

Gozolits
S
Fischer
G
Berger
T
Hanser
F
Abou-Harb
M
Tilg
B
et al.
Global P wave duration on the 65-lead ECG: single-site and dual-site pacing in the structurally normal human atrium.
J Cardiovasc Electrophysiol
2002
13
1240
5
.

52

Roithinger
FX
Abou-Harb
M
Pachinger
O
Hintringer
F
The effect of the atrial pacing site on the total atrial activation time.
Pacing Clin Electrophysiol
2001
24
316
22
.

53

Yu
WC
Tsai
CF
Hsieh
MH
Chen
CC
Tai
CT
Ding
YA
et al.
Prevention of the initiation of atrial fibrillation: mechanisms and efficacy of different atrial pacing modes.
Pacing Clin Electrophysiol
2000
23
373
9
.

54

Padeletti
L
Michelucci
A
Pieragnoli
P
Colella
A
Musilli
N
Atrial septal pacing: a new approach to prevent atrial fibrillation.
Pacing Clin Electrophysiol
2004
27
850
4
.

55

Bailin
SJ
Adler
S
Giudici
M
Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial.
J Cardiovasc Electrophysiol
2001
12
912
7
.

56

De Voogt
W
De Vusser
P
Stockman
D
Van den Bos
A
Anelli-Monti
M
Mairesse
G
et al.
Atrial fibrillation suppression reduces atrial fibrillation burden on patients with paroxysmal atrial fibrillation and class 1 and 2 pacemaker indication—the OASES study. (Abstract).
Eur Heart J
2003
24
suppl
369
.

57

Hettrick
DA
Euler
DE
Pagel
PS
Musley
SK
Warman
EN
Ziegler
PD
et al.
Atrial pacing lead location alters the effects of atrioventricular delay on atrial and ventricular hemodynamics.
Pacing Clin Electrophysiol
2002
25
888
96
.

58

Hettrick
DA
Mittelstadt
JR
Kehl
F
Kress
TT
Tessmer
JP
Krolikowski
JG
et al.
Atrial pacing lead location alters the hemodynamic effects of atrial-ventricular delay in dogs with pacing induced cardiomyopathy.
Pacing Clin Electrophysiol
2003
26
853
61
.

59

Barold
SS
Israel
CW
Israel
CW
Barold
SS
Prevention of atrial fibrillation by conventional permanent antibradycardia pacemakers. Evaluation of nonrandomized studies.
Advances in the Treatment of Atrial Tachyarrhythmia. Pacing, Cardioversion, and Defibrillation
Armonk, NY
Futura Publishing Co. Inc
2002
41
60
.

Supplementary data